Success Stories: In Only 10 Days, A Postdoctoral Researcher from Pakistan Secures NIW Approval in the Field of Biotechnology
Client’s Testimonial:
“Thank you for the good news! This happened because of your hard work (preparing the case till it's filed) ... Simply the best and most professional team. Thank you once again to the whole team!”
On October 12th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Pakistan
State of Residence at the Time of Filing: Texas
Approval Notice Date: October 12th, 2023
Processing Time: 10 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group was hired by a Pakistani postdoctoral researcher to prepare a strong EB-2 NIW (National Interest Waiver) petition. We began by asking her to mail us a thorough background check, both professionally and educationally.
In 2022, our client earned a Ph.D. in animal biotechnology and finished her studies outside of the United States. She provided us with copies of her transcripts, diploma, and degree certificate as proof of this. We thoroughly examined her educational background and deduced that she is therefore eligible to work in the professions for which she has an advanced degree.
As an expert in the field of biotechnology, our client’s proposed endeavor is to continue her research on developing a more successful hormone therapy strategy for uterine cancers, specifically leiomyosarcomas. This will help identify particular biomarkers that distinguish rare cancers and diagnose prognostic factors early in patients' lives.
In addition, we affirmed that her work is relevant to the advancement of hormone treatment and cancer therapy based on her qualifications. Also, the significance of her initiative lies in its contribution to the progress of cancer treatment and the expanding worldwide market for cancer therapies.
Moreover, we noted the fact that our client published 8 peer-reviewed journal articles (2 of them first-authored) in no fewer than 6 highly-ranked peer-reviewed journals was additional proof that her peers valued her research. Her work was cited a total of 80 times by other specialists in the field of biotechnology, who relied on her work.
Furthermore, we specified that she has been frequently approached to provide peer reviews for reputable journals in the industry because of her knowledge and proficiency. To date, she has conducted at least one review. Therefore, she is regarded as extremely competent in the field.
Additionally, the National Research Foundation of Korea (NRF) has provided financial support for her work. Projects that use cutting-edge research to enhance quality of life are supported by this funding. Her research so undoubtedly contributes significantly to the protection of human health by identifying vital avenues of defense against BPA harm.
The aforementioned data also illustrates the importance of her research for both the U.S. economy and public health. Considering that uterine cancer is the most frequent gynecologic cancer in the U.S. and predicts the death of over 13,000 American women in a year alone, there is an especially pressing need for her continued contributions on a national level. Her vast knowledge in proteomics, genomics, and the molecular underpinnings of endocrine disruption will be a major asset to efforts to lower the incidence and death rates of uterine cancer in the United States.
That being stated, we are glad that her NIW petition was approved 10 days after we submitted her case to USCIS with the premium processing service upgrade. We are appreciative of her gracious collaboration with our legal team during the process and for permitting us to compose this remarkable story of approval. We wish her the best of luck in all of her future endeavors.